Miller-Rich Nancy
Insider CIK 1735084 · ICPT Director · ALDX Director · KDMN Director · FDMT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2026-06-17 | 2026-06-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 3,318 | — | $0 | 3,318 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 70,000 | — | $0 | 70,000 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2025-06-17 | 2025-06-20 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 2,413 | — | $0 | 2,413 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 62,728 | — | $0 | 62,728 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 40,282 | — | $0 | 40,282 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 1,736 | — | $0 | 1,736 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2024-05-21 | 2024-05-23 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,547 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,174 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 7,684 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,966 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,790 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,089 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | U Tender | 2023-11-08 | 2023-11-13 | 22,304 | $19.00 | $423.8K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer | 2023-11-08 | 2023-11-13 | 8,111 | $19.00 | $154.1K | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2023-06-30 | 2023-07-05 | 915 | — | $0 | 915 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2023-06-30 | 2023-07-05 | 21,222 | — | $0 | 21,222 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2023-05-24 | 2023-05-25 | 12,547 | — | $0 | 12,547 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2023-05-24 | 2023-05-25 | 8,111 | — | $0 | 30,415 | SEC↗ |
| FMDT 4D Molecular Therapeutics, | A Award deriv | 2023-05-23 | 2023-05-25 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2023-04-12 | 2024-10-21 | 509 | $10.13 | $5.2K | 922 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 2,319 | — | $0 | 2,319 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 53,812 | — | $0 | 53,812 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2022-05-25 | 2022-05-27 | 12,790 | — | $0 | 12,790 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2022-05-25 | 2022-05-27 | 7,737 | — | $0 | 22,304 | SEC↗ |
| FDMT 4D Molecular Therapeutics, | A Award deriv | 2022-05-23 | 2022-05-25 | 22,500 | — | $0 | 22,500 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 36,364 | $5.33 | $193.8K | 0 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | D To issuer deriv | 2021-11-09 | 2021-11-09 | 96,975 | $5.92 | $574.1K | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2021-06-08 | 2021-06-10 | 13,534 | — | $0 | 13,534 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2021-06-08 | 2021-06-10 | 583 | — | $0 | 583 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2021-05-27 | 2021-06-01 | 12,089 | — | $0 | 12,089 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-05-27 | 2021-06-01 | 7,029 | — | $0 | 14,567 | SEC↗ |
| FDMT 4D Molecular Therapeutics | A Award deriv | 2021-05-17 | 2021-05-19 | 22,500 | — | $0 | 22,500 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2021-05-12 | 2021-05-13 | 96,975 | — | $0 | 96,975 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2021-05-03 | 2024-10-21 | 413 | $12.81 | $5.3K | 413 | SEC↗ |
| KDMN Kadmon Holdings, Inc. | A Award deriv | 2020-08-13 | 2020-08-13 | 36,364 | $4.17 | $151.6K | 36,364 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 26,503 | — | $0 | 26,503 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2020-05-28 | 2020-06-01 | 2,966 | — | $0 | 2,966 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2020-05-28 | 2020-06-01 | 1,595 | — | $0 | 7,538 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2020-01-13 | 2020-01-15 | 24,264 | — | $0 | 24,264 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2019-06-20 | 2019-06-21 | 2,174 | — | $0 | 2,174 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2019-06-20 | 2019-06-21 | 1,570 | — | $0 | 5,943 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2018-06-20 | 2018-06-22 | 7,684 | — | $0 | 7,684 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2018-06-20 | 2018-06-22 | 4,373 | — | $0 | 4,373 | SEC↗ |